FDA clears TRIA's acne treatment device for OTC
This article was originally published in The Rose Sheet
Executive Summary
TRIA Beauty is planning a spring 2010 launch for its blue light device designed for home treatment of acne, after receiving over-the-counter clearance from FDA, firm announces. The device will debut on TRIABeauty.com and at select retailers. Firm says its blue light technology is 10 times more powerful than other OTC blue light devices, and that it delivers clear skin faster with shorter treatment times. TRIA cites clinical studies demonstrating the technology "cleared breakouts as quickly and effectively as professional blue light treatments." The company's home-use permanent laser hair-removal device received FDA approval in 2007; it retails for $595 (1"The Rose Sheet" Nov. 9. 2009)
You may also be interested in...
TRIA Enhances Home Hair-Removal Device, Lowers Price In Time For Holidays
TRIA Beauty has upgraded its laser hair-removal device, knocked $200 off the price and launched a multimedia marketing campaign to entice shoppers this holiday season
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.